PD-L1 is also highly expressed on dendritic cells, crucial in the anti-tumor response in melanoma [15], and the binding of PD-1/PD-L1 on CD8+ T cells and dendritic cells has been shown to also downregulate CD8+ T cell activity [16]. This evidence concerns the gene CD8A and neoplasm.